Dapagliflozin and cardiovascular outcomes in type 2 diabetes

DECLARE–TIMI 58 Investigators

Research output: Contribution to journalArticlepeer-review

2841 Scopus citations

Fingerprint

Dive into the research topics of 'Dapagliflozin and cardiovascular outcomes in type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences